View in EDS

Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis.

Saved in:
Bibliographic Details
Title: Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis.
Authors: Grogan M; Cardiovascular Medicine Department, Mayo Clinic, Rochester, MN 55905, USA., Sheikh FH; MedStar Heart and Vascular Institute, MedStar Health/Georgetown University School of Medicine, Washington, DC 20007, USA., Sperry BW; Saint Luke's Mid America Heart Institute, Kansas City, MO 64111, USA., Sweetser MT; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA., Capocelli K; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA., Roblin S; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA., Witteles R; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Source: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2025 Jun 10; Vol. 36 (3), pp. 102590. Date of Electronic Publication: 2025 Jun 10 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40686854
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grogan+M%22">Grogan M</searchLink>; Cardiovascular Medicine Department, Mayo Clinic, Rochester, MN 55905, USA.<br /><searchLink fieldCode="AU" term="%22Sheikh+FH%22">Sheikh FH</searchLink>; MedStar Heart and Vascular Institute, MedStar Health/Georgetown University School of Medicine, Washington, DC 20007, USA.<br /><searchLink fieldCode="AU" term="%22Sperry+BW%22">Sperry BW</searchLink>; Saint Luke's Mid America Heart Institute, Kansas City, MO 64111, USA.<br /><searchLink fieldCode="AU" term="%22Sweetser+MT%22">Sweetser MT</searchLink>; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Capocelli+K%22">Capocelli K</searchLink>; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Roblin+S%22">Roblin S</searchLink>; Alnylam Pharmaceuticals, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Witteles+R%22">Witteles R</searchLink>; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2025 Jun 10; Vol. 36 (3), pp. 102590. <i>Date of Electronic Publication: </i>2025 Jun 10 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40686854
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omtn.2025.102590
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102590
    Titles:
      – TitleFull: Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grogan M
      – PersonEntity:
          Name:
            NameFull: Sheikh FH
      – PersonEntity:
          Name:
            NameFull: Sperry BW
      – PersonEntity:
          Name:
            NameFull: Sweetser MT
      – PersonEntity:
          Name:
            NameFull: Capocelli K
      – PersonEntity:
          Name:
            NameFull: Roblin S
      – PersonEntity:
          Name:
            NameFull: Witteles R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 06
              Text: 2025 Jun 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2162-2531
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular therapy. Nucleic acids
              Type: main
ResultId 1